rawfin.tv
Entera Bio CEO Scheduled to Speak at Canaccord Genuity Conference in 2026
MarketsstocksAI Generated

Entera Bio CEO Scheduled to Speak at Canaccord Genuity Conference in 2026

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Entera Bio Ltd. announced that CEO Miranda Toledano will present at the Canaccord Genuity Growth Conference on August 12, 2026. The clinical-stage company focuses on oral peptide therapies, and the presentation will offer updates on its pipeline.

ENTXbiotechconferencecompany-newsinvestor-relations

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks